buparvaquone has been researched along with Leishmaniasis, Cutaneous in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Croft, SL; Garnier, T; Järvinen, T; Koskinen, A; Mäntylä, A; Nevalainen, T; Rautio, J; Vepsälainen, J | 1 |
Adewusi, O; Adriana de Jesus, J; Auxiliadora Dea-Ayuela, M; Bolas-Fernandez, F; Dalastra Laurenti, M; Felipe Domingues Passero, L; Lalatsa, A; Serrano, DR; Statts, L | 1 |
Awan, MM; Jamal, Q; Khan, NH; Shah, A; Sutherland, C; Wahid, S | 1 |
Aguiar, MG; Carneiro, G; Fernandes, AP; Ferreira, LA | 1 |
Brown, MB; Croft, SL; Garnier, T; Järvinen, T; Lawrence, MJ; Mäntylä, A | 1 |
Brown, M; Croft, S; Garnier, T; Järvinen, T; Lawrence, J; Mäntylä, A | 1 |
1 review(s) available for buparvaquone and Leishmaniasis, Cutaneous
Article | Year |
---|---|
Drug delivery systems for the topical treatment of cutaneous leishmaniasis.
Topics: Administration, Cutaneous; Aminoquinolines; Amphotericin B; Animals; Antiprotozoal Agents; Drug Delivery Systems; Humans; Imiquimod; Leishmaniasis, Cutaneous; Naphthoquinones; Paromomycin; Phosphorylcholine; Skin Absorption | 2012 |
5 other study(ies) available for buparvaquone and Leishmaniasis, Cutaneous
Article | Year |
---|---|
Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone.
Topics: Administration, Oral; Administration, Topical; Alkaline Phosphatase; Animals; Antiprotozoal Agents; Cricetinae; Female; Humans; Hydrolysis; In Vitro Techniques; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Macrophages, Peritoneal; Mice; Naphthoquinones; Organophosphates; Permeability; Prodrugs; Skin; Solubility; Water | 2004 |
Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Hydrogels; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Naphthoquinones | 2020 |
In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Cell Line, Tumor; Child; Humans; Inhibitory Concentration 50; Leishmania tropica; Leishmaniasis, Cutaneous; Macrophages; Male; Meglumine; Meglumine Antimoniate; Naphthoquinones; Organometallic Compounds; Pakistan; Parasitic Sensitivity Tests | 2015 |
Topical buparvaquone formulations for the treatment of cutaneous leishmaniasis.
Topics: Administration, Cutaneous; Animals; Antiprotozoal Agents; Chemistry, Pharmaceutical; Ethanol; Female; Humans; In Vitro Techniques; Leishmaniasis, Cutaneous; Melanins; Mice; Mice, Inbred BALB C; Myristates; Naphthoquinones; Organophosphates; Polyethylene Glycols; Prodrugs; Propylene Glycol; Skin; Skin Absorption | 2007 |
In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs.
Topics: Animals; Antiprotozoal Agents; Chemistry, Pharmaceutical; Female; Leishmania donovani; Leishmania major; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liver; Mice; Mice, Inbred BALB C; Naphthoquinones; Prodrugs; Skin | 2007 |